Top 5 Formulary Watch Articles of 2024

1. UnitedHealthcare Adds Deductibles to Medicare Part D for 2025

UnitedHealthcare is adding deductibles to Part D prescriptions on certain formulary tiers as a result of plan design changes from the Inflation Reduction Act.

Read here

2. NDA Resubmitted for Dry Eye Treatment Reproxalap

Dry eye disease affects up to 15% of the U.S. population and is one of the largest markets in the ophthalmology field.

Read here

3. CVS Caremark Makes Changes in Diabetes Coverage for 2025

CVS Caremark has removed several diabetes drugs favor of newer products and generics and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.

Read here

4. 2024 Formulary Moves

The large pharmacy benefit managers have switched up their coverage of biosimilars, especially the biosimilars to Humira (adalimumab).

Read here

5. FDA Approves Dupixent for Patients with COPD

This is the sixth indication for Dupixent and the only biologic approved in the United States to treat COPD.

Read here